14-day Premium Trial Subscription Sign Up For FreeGet Free

ABIOMED Stock Forecast NASDAQ:ABMD

Price Target and Analyst Ratings

Most Recent Rating

On August 06, 2021 "SVB Leerink" gave "$335.00 - $375.00" rating for ABMD. The price target was set to $348.86+5.3%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-06 $335.00 - $375.00 Target Raised by SVB Leerink $345.88 $348.86+5.3%
2021-08-06 $360.00 - $410.00 Target Raised by Deutsche Bank Aktiengesellschaft $345.88 $348.86+5.3%
2021-07-20 $355.00 - $335.00 Target Lowered by SVB Leerink $323.59 $318.36+1.2%
2021-06-18 $360.00 Initiated by Deutsche Bank Aktiengesellschaft $318.57 $324.77→0.1%
2021-06-18 Buy Initiated by Deutsche Bank Aktiengesellschaft $318.57 $360.00
2021-06-06 Hold Reiterated by SVB Leerink $289.51
2021-01-29 Market Perform Target Raised by SVB Leerink $348.25 $320.00 → $375.00
2021-01-29 Underweight Target Raised by Morgan Stanley $348.25 $238.00 → $245.00
2021-01-28 Overweight Target Raised by Piper Sandler $355.13 $350.00 → $425.00
2020-12-21 Positive - Market Perform Target Raised by SVB Leerink $295.81 $280.00 → $320.00
2020-12-15 Underweight Target Raised by Morgan Stanley $275.36 $217.00 → $238.00
2020-10-12 Market Perform Target Lowered by SVB Leerink $277.85 $335.00 → $280.00
2020-08-07 Market Perform Target Raised by SVB Leerink $310.82 $280.00 → $335.00
2020-08-07 Underweight Target Raised by Morgan Stanley $310.82 $152.00 → $217.00
2020-07-13 Positive Upgraded by OTR Global $264.55
2020-05-28 Market Perform Target Raised by SVB Leerink $217.36 $195.00 → $225.00
2020-05-27 Hold Downgraded by BTIG Research $207.76
2020-05-01 Underweight Target Raised by Morgan Stanley $183.49 $149.00 → $152.00
2020-04-27 Outperform - Market Perform Downgraded by SVB Leerink $163.47 $220.00 → $175.00

ABMD Stock Trend

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $343.15 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift.

Given the current short-term trend, the stock is expected to rise 16.47% during the next 3 months and, with a 90% probability hold a price between $399.67 and $447.20 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-22 $344.02 $364.42 $384.82
2021-09-23 $344.88 $365.28 $385.68
2021-09-24 $345.74 $366.14 $386.54
2021-09-27 $346.60 $367.00 $387.41
2021-09-28 $347.46 $367.87 $388.27
2021-09-29 $348.33 $368.73 $389.13
2021-09-30 $349.19 $369.59 $389.99
2021-10-01 $350.05 $370.45 $390.85
2021-10-04 $350.91 $371.31 $391.72
2021-10-05 $351.77 $372.18 $392.58
2021-10-06 $352.64 $373.04 $393.44
2021-10-07 $353.50 $373.90 $394.30
2021-10-08 $354.36 $374.76 $395.16
2021-10-11 $355.22 $375.62 $396.03
2021-10-12 $356.08 $376.49 $396.89
2021-10-13 $356.95 $377.35 $397.75
2021-10-14 $357.81 $378.21 $398.61
2021-10-15 $358.67 $379.07 $399.47
2021-10-18 $359.53 $379.93 $400.34
2021-10-19 $360.39 $380.80 $401.20
2021-10-20 $361.26 $381.66 $402.06
2021-10-21 $362.12 $382.52 $402.92
2021-10-22 $362.98 $383.38 $403.78
2021-10-25 $363.84 $384.24 $404.65
2021-10-26 $364.70 $385.11 $405.51
2021-10-27 $365.57 $385.97 $406.37
2021-10-28 $366.43 $386.83 $407.23
2021-10-29 $367.29 $387.69 $408.09
2021-11-01 $368.15 $388.55 $408.96
2021-11-02 $369.01 $389.42 $409.82

About ABIOMED

ABIOMED ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP that provides partial circulatory support using an extracorporeal bypass control unit; I... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT